- Home
- BNC vs CDXS Comparison
BNC vs CDXS Comparison
Compare BNC & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNC | CDXS |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Major Chemicals |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.3M | 256.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | BNC | CDXS |
|---|---|---|
| Price | $2.50 | $2.80 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 287.0K | ★ 910.5K |
| Earning Date | 07-24-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $138,590,000.00 |
| Revenue This Year | N/A | $7.73 |
| Revenue Next Year | N/A | $14.24 |
| P/E Ratio | $0.22 | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $2.24 | $0.96 |
| 52 Week High | $31.62 | $3.87 |
Technical Indicators
Market Signals| Indicator | BNC | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 59.28 |
| Support Level | $2.31 | $2.39 |
| Resistance Level | $3.05 | $2.87 |
| Average True Range (ATR) | 0.29 | 0.15 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 51.85 | 79.28 |
Price Performance
Historical ComparisonAbout BNC CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.
About CDXS Codexis Inc.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.